Get Premium to unlock powerful stock data
NAS:FATE (USA)   Healthcare » Biotechnology
Fate Therapeutics Inc logo

Fate Therapeutics Inc $ 61.24 -1.27 (-2.03%)

Volume:
807,857
Avg Vol (1m):
1,149,100
Market Cap $:
5.83 Bil
Enterprise Value $:
5.36 Bil
PE Ratio:
At Loss
PB Ratio:
7.68
Warning! GuruFocus has detected 2 Severe warning signs with FATE. Click here to check it out.
Also Trade In: Germany
EMBED
5D 3M YTD 1Y 3Y 5Y 10Y All 10Y -%
Above Low: +NaN%
Below High: NaN%

Fate Therapeutics Inc Stock Institutional Ownership and Insider Ownership -

95.18
(Mil)
Shares Outstanding
83.48%
79.46 (Mil)
Institutional Ownership
1.24%
1.18 (Mil)
Insider Ownership
71.50%
68.0513 (Mil)
Float Percentage of TSO

Short Interest History (%)

Due to a license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus’ website, except for certain Australian stocks.

Institutional Ownership History (%)

This the Institutional Ownership History of Fate Therapeutics Inc. Peter Lynch prefers to buy companies with low institutional ownership.
EMBED

Insider ownership (%)

This is the historical insider ownership of Fate Therapeutics Inc. It is usually better to buy companies with large insider ownership. The company insiders' interest are more aligned with external shareholders in this case.

Top Direct Holders

Top Fund Holders